Systemic effects of melanoma-secreted MIDKINE in the inhibition of dendritic cell differentiation and function
X. Catena, M. Contreras, D. Cerezo-Wallis, N. J. Larrea, D. Olmeda, G. G. Calvo, C. Mucientes, S. Oterino, M. S. Soengas
This study identifies MIDKINE as a factor secreted by melanomas that inhibits dendritic cell differentiation and function, contributing to immune resistance in melanoma.
bioRxiv · Dec 28, 2022 · PreprintCancer Biology